4D Molecular Therapeutics Inc FDMT:NASDAQ

Last Price$22.05NASDAQ Previous Close - Last Trade as of 1:00PM ET 11/26/21

Today's Change-0.44(1.96%)
Bid (Size)$16.00 (2)
Ask (Size)$26.00 (14)
Day Low / High$21.51 - 22.82
Volume111.5 K
 

Read more news Recent News

-- Earnings Flash (FDMT) 4D MOLECULAR THERAPEUTICS Reports Q3 Revenue $1.4M
4:03PM ET 11/10/2021 MT Newswires

...

Update: 4D Molecular Therapeutics Prices Stock Offering at $25 Per Share; Shares Decline
2:00PM ET 10/29/2021 MT Newswires

(Updates with stock movement in second paragraph) 4D Molecular Therapeutics (FDMT) said on Thursday that it priced an underwritten public offering of 4.75...

4D Molecular Therapeutics Prices Stock Offering at $25 Per Share
4:51AM ET 10/29/2021 MT Newswires

4D Molecular Therapeutics (FDMT) said on Thursday that it priced an underwritten public offering of 4.75 million shares of its common stock at a public...

4D Molecular Therapeutics Commences Public Offering of 4.5 Million Common Shares
3:19AM ET 10/27/2021 MT Newswires

4D Molecular Therapeutics (FDMT) late Tuesday said it has commenced a brokered public offering of 4.5 million common shares. The company said it plans to...

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/10/20218-K

Company Highlights

Price Open$22.06
Previous Close$22.49
52 Week Range$21.25 - 55.11
Market Capitalization$708.6 M
Shares Outstanding32.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.02
Beta vs. S&P 500N/A
RevenueN/A
Net Profit Margin-213.14%
Return on Equity-30.58%

Analyst Ratings as of 01/05/2021

Buy
2
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset